News

A recent 3-part series details the inevitability of another global influenza pandemic and how better surveillance and new vaccines may protect us in time for the next pandemic.

The investigators used a combined approach of LASER ART and CRISPR-Cas9 to successfully eliminate replication-competent HIV-1 DNA from the genome of living mice.

The popular tourist destination makes headlines for all the wrong reasons thanks to mysterious incidents involving 13 Americans.

A new matrix will help prepare multiple industries to combat potential Ebola occupational exposures

Bacteriophages found in kitchen sponges may hold promise for the treatment of antimicrobial-resistant bacterial infections.

Traditional testing for river blindness, a neglected tropical disease that World Health Organization aims to eradicate, is not as sensitive as it could be.

Investigators identified a patient in the US infected with Salmonella resistant to colistin, the drug of last resort, raising concerns about the spread of multidrug-resistant microbes.

A new study looks at ESBL transmission and close proximity interactions.

Read Contagion®’s full Q&A with Dr. Drew Pinsky on the explosion of infectious diseases on the Pacific Coast tied to the humanitarian crisis there.

CDC is warning consumers in several states to dispose of whole, fresh papayas imported from Mexico following the detection of a multistate outbreak of Salmonella Uganda.

The global emergence of antimicrobial resistance among gram-negative species is a major public health concern.

A single antibody, A1431, showed broad blockade toward tested GII.4 strains and was able to neutralize the pandemic GII.P16-GII.4 Sydney strain of norovirus.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of June 23, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

There have been 32 confirmed cases of the rare bacterial infection in southeastern England’s Mid Essex, mostly among elderly individuals receiving chronic wound care.

As injectable influenza vaccine doses from the 2018-19 season are set to expire on June 30, 2019, CDC investigators detail 192 cases of expired vaccine administration over the last year.

As June draws to a close, the Contagion® editorial staff is recapping the trends and top infectious disease news of the month.

The FDA approved the first darunavir-based single-tablet regimen for the treatment of HIV in July 2018. How is it working out for patients and providers alike?

PHOENIx MDR-TB is comparing the safety and efficacy of delamanid, a new drug, with the older TB drug isoniazid for preventing active MDR-TB among individuals exposed to the disease.

Testing and information will be available at select Walgreens stores in more than 260 cities on National HIV Testing Day on Thursday between 10 am and 7 pm.

ACIP voted 10-to-4 to expand the recommended HPV vaccine “catch-up” age for men from 21 to 26, matching the existing guidelines for women.

The recommendation means more patients will be able to access PrEP at no cost. However, it likely won’t be enough to dramatically boost PrEP usage without other systemic advances.

RSV is a pernicious pathogen that may spread easily among the homeless and possibly cause more severe disease.

With investments in novel drugs on the decline, the decision on whether or not to use a new product may serve to foster or stunt development.

The 2018-19 US flu season lasted 21 weeks, marking the longest season in a decade.

According to a press release issued by the manufacturer, the products are the therapeutic equivalent to Genentech’s Tamiflu capsules.

A symposium at ASM Microbe 2019 considered some specific examples of how bacteriophage shape the microbiome and also zoomed out for a higher-altitude view of the microbiome.